Kimia Biosciences Limited (BOM:530313)
27.61
-1.91 (-6.47%)
At close: Sep 11, 2026
Kimia Biosciences Market Cap
Kimia Biosciences has a market cap or net worth of 1.31 billion as of September 11, 2026. Its market cap has decreased by -23.13% in one year.
Market Cap
1.31B
Enterprise Value
1.65B
Revenue
1.12B
Ranking
n/a
PE Ratio
17.23
Stock Price
27.61
ChartMarket Cap Chart
Since May 17, 2016, Kimia Biosciences's market cap has increased from 68.68M to 1.31B, an increase of 1,802.00%. That is a compound annual growth rate of 33.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 1.31B | -18.67% |
| Dec 31, 2025 | 1.61B | -25.63% |
| Dec 31, 2024 | 2.16B | 24.05% |
| Dec 29, 2023 | 1.74B | -14.42% |
| Dec 30, 2022 | 2.03B | -30.19% |
| Dec 31, 2021 | 2.91B | 33.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aarey Drugs & Pharmaceuticals | 2.72B |
| Accretion Nutraveda | 2.04B |
| Resonance Specialties | 1.98B |
| Smruthi Organics | 1.85B |
| Auro Laboratories | 1.60B |
| Panchsheel Organics | 1.46B |
| Krebs Biochemicals & Industries | 1.33B |
| Tyche Industries | 1.15B |